Literature DB >> 22615451

Molecular pathways: interferon/stat1 pathway: role in the tumor resistance to genotoxic stress and aggressive growth.

Nikolai N Khodarev1, Bernard Roizman, Ralph R Weichselbaum.   

Abstract

STAT1 is activated by IFNs and other cell signals. Following activation, STAT1 is translocated to the nuclei and activates transcription of IFN-stimulated genes. Although the activation of STAT1 by IFNs is classically associated with antiviral defense and tumor-suppressive functions, emerging data indicate that expression of the STAT1 pathway confers cellular resistance to DNA-damaging agents and mediates aggressive tumor growth. Recent advances in the development of Janus-activated kinase/Stat inhibitors and peptide inhibitors specific for individual Stat proteins may provide new insights into the controversial functions of this pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22615451     DOI: 10.1158/1078-0432.CCR-11-3225

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  91 in total

1.  Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer.

Authors:  Merit L Goodman; Gloria M Trinca; Katherine R Walter; Evangelia K Papachristou; Clive S D'Santos; Tianbao Li; Qi Liu; Zhao Lai; Prabhakar Chalise; Rashna Madan; Fang Fan; Mary A Markiewicz; Victor X Jin; Jason S Carroll; Christy R Hagan
Journal:  J Immunol       Date:  2019-04-01       Impact factor: 5.422

2.  Activities of multiple cancer-related pathways are associated with BRAF mutation and predict the resistance to BRAF/MEK inhibitors in melanoma cells.

Authors:  Dingxie Liu; Xuan Liu; Mingzhao Xing
Journal:  Cell Cycle       Date:  2013-10-29       Impact factor: 4.534

Review 3.  Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.

Authors:  Rosalba Camicia; Hans C Winkler; Paul O Hassa
Journal:  Mol Cancer       Date:  2015-12-11       Impact factor: 27.401

4.  G3BP1 and G3BP2 regulate translation of interferon-stimulated genes: IFITM1, IFITM2 and IFITM3 in the cancer cell line MCF7.

Authors:  Umber Alam; Derek Kennedy
Journal:  Mol Cell Biochem       Date:  2019-06-06       Impact factor: 3.396

Review 5.  Radiotherapy and immunotherapy: a beneficial liaison?

Authors:  Ralph R Weichselbaum; Hua Liang; Liufu Deng; Yang-Xin Fu
Journal:  Nat Rev Clin Oncol       Date:  2017-01-17       Impact factor: 66.675

Review 6.  Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models.

Authors:  Katherine A Leehy; Thu H Truong; Laura J Mauro; Carol A Lange
Journal:  J Steroid Biochem Mol Biol       Date:  2017-04-23       Impact factor: 4.292

7.  Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones.

Authors:  Go Oshima; Melinda E Stack; Sean C Wightman; Darren Bryan; Elizabeth Poli; Lai Xue; Kinga B Skowron; Abhineet Uppal; Sean P Pitroda; Xiaona Huang; Mitchell C Posner; Samuel Hellman; Ralph R Weichselbaum; Nikolai N Khodarev
Journal:  J Vis Exp       Date:  2016-11-30       Impact factor: 1.355

8.  hCAF1/CNOT7 regulates interferon signalling by targeting STAT1.

Authors:  Clément Chapat; Chloé Kolytcheff; Muriel Le Romancer; Didier Auboeuf; Pierre De La Grange; Kamel Chettab; Stéphanie Sentis; Laura Corbo
Journal:  EMBO J       Date:  2013-02-05       Impact factor: 11.598

9.  RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation.

Authors:  Ryan C Widau; Akash D Parekh; Mark C Ranck; Daniel W Golden; Kiran A Kumar; Ravi F Sood; Sean P Pitroda; Zhengkai Liao; Xiaona Huang; Thomas E Darga; David Xu; Lei Huang; Jorge Andrade; Bernard Roizman; Ralph R Weichselbaum; Nikolai N Khodarev
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

10.  Tumor STAT1 transcription factor activity enhances breast tumor growth and immune suppression mediated by myeloid-derived suppressor cells.

Authors:  Laura M Hix; John Karavitis; Mohammad W Khan; Yihui H Shi; Khashayarsha Khazaie; Ming Zhang
Journal:  J Biol Chem       Date:  2013-03-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.